| Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484) |
|---|
| 05/09/2006 | US7041675 Invention also relates to the tautomeric forms, and possible enantiomeric and diastereomeric forms of said compounds, to the prodrugs thereof and to their use as PARP inhibitors. |
| 05/09/2006 | US7041669 1,4-benzofused urea compounds useful in treating cytokine mediated diseases |
| 05/09/2006 | US7041665 Central nervous system disorders; anxiolytic agents; antidepressants; antiepilepsy agents; antiarthritic agents |
| 05/09/2006 | US7041659 Compounds for the treatment of metabolic disorders |
| 05/09/2006 | US7041657 Topical semi-crystalline beta-1,4-n-acetylglucosamine polymers free of proteins and contaminants; stimulating endothelin-1 release, vasoconstriction, and/or reduction in blood flow out of a breached vessel |
| 05/09/2006 | US7041653 Gene transcription and ionizing radiation: methods and compositions |
| 05/09/2006 | US7041652 administering ascorbic acid, ascorbate or a derivative thereof in combination with quercetin-3-O-glucoside (isoquercetin), quercetin-4'-glucoside, quercetin-3'-glucoside, or quercetin-7-glucoside to increase bioavailability |
| 05/09/2006 | US7041461 Nucleotide sequences coding membrame protein for use in analgesics |
| 05/09/2006 | US7041314 GPE analogs and peptidominetics |
| 05/09/2006 | US7041303 Use of moxonidine for postmyocardial infarction treatment |
| 05/09/2006 | US7041063 Noninvasive measurement of chemical substances |
| 05/09/2006 | US7040314 Aerosol generating devices and methods for generating aerosols suitable for forming propellant-free aerosols |
| 05/09/2006 | CA2418908C 1,4-dihydropyridines as bradykinin antagonists |
| 05/09/2006 | CA2322501C Processes for the preparation of (r)-.alpha.-(2,3-dimethoxyphenyl)-1-[2-(4-fluorophenyl)ethyl]-4-piperidinemethanol |
| 05/09/2006 | CA2257328C Thiazole derivatives |
| 05/09/2006 | CA2125105C Substituted benzoylguanidines, process for their preparation, their use as a medicament or diagnostic and medicament containing them |
| 05/04/2006 | WO2006047504A1 Aromatic amides as inhibitors of c-fms kinase |
| 05/04/2006 | WO2006047262A1 4 [(2,4-dichloro-5-methoxyphenyl)amino]-6-alkoxy-7-ethynyl-3-quinolinecarbonitriles for the treatment of ischemic injury |
| 05/04/2006 | WO2006047172A1 Tweak receptor |
| 05/04/2006 | WO2006046933A1 Sedative and spasmolytic medicinal agent and method for the production thereof (variants) |
| 05/04/2006 | WO2006046910A1 Novel use |
| 05/04/2006 | WO2006046779A1 Carbazole derivative, solvate thereof, or pharmaceutically acceptable salt thereof |
| 05/04/2006 | WO2006046766A1 Gene therapy for treatment of cardiac failure |
| 05/04/2006 | WO2006046739A1 Remedy for inflammatory diseases |
| 05/04/2006 | WO2006046626A1 Water-soluble elastins, process for producing the same, and food and medicine containing the same |
| 05/04/2006 | WO2006046623A1 Solid medicinal preparation improved in solubility and stability and process for producing the same |
| 05/04/2006 | WO2006046584A1 Remedy for visual cell injuries |
| 05/04/2006 | WO2006046583A1 Material for regenerating visual cells or functions thereof |
| 05/04/2006 | WO2006046569A1 Neuronal differentiation promoting peptide |
| 05/04/2006 | WO2006046557A1 Abnormal protein removing composition |
| 05/04/2006 | WO2006046492A1 Novel ppar regulating agent and method of screening the same |
| 05/04/2006 | WO2006046065A1 Botulinum toxin therapy of heart rhythm disorders |
| 05/04/2006 | WO2006046043A1 Process for the preparation of irbesartan hydrochloride |
| 05/04/2006 | WO2006045565A1 Xanthine derivatives with hm74a receptor activity |
| 05/04/2006 | WO2006045564A1 Xanthine derivatives with hm74a receptor activity |
| 05/04/2006 | WO2006045238A1 Carbonized pollen and the use thereof for the preparation of anticancer drugs |
| 05/04/2006 | WO2006045204A1 Aryl sulfonic pyridoxines as antiplatelet agents |
| 05/04/2006 | WO2006045203A1 Substituted pyridoxines as anti-platelet agents |
| 05/04/2006 | WO2006036512A3 Unsubstituted and substituted 4-benzyl-1,3-dihydro-imidazole-2-thiones acting as specific or selective alpha2 adrenergic agonists and methods for using the same |
| 05/04/2006 | WO2006025889A3 Inhibition of atherosclerosis by diindolylmethane analogs |
| 05/04/2006 | WO2006003290A3 Sulphated depolymerised derivatives of exopolysaccharides (eps), preparation and uses thereof |
| 05/04/2006 | WO2006003289A3 Sulphated polysaccharide derivatives for modulating angiogenesis |
| 05/04/2006 | WO2005123718A3 Benzimidazolone carboxylic acid derivatives |
| 05/04/2006 | US20060094902 Amino acid analogues |
| 05/04/2006 | US20060094783 Use of R-enantiomer of N-propargyl-1-aminoindan, salts, compositions and uses thereof |
| 05/04/2006 | US20060094771 Carvedilol pharmasolve solvate |
| 05/04/2006 | US20060094769 e.g. methyl 4-{[(5-ethoxy-5-oxopentyl)(2-methoxyphenethyl)amino]methyl}benzoate; stimulant of guanylate cyclase; catalyse the biosynthesis of cGMP from guanosine triphosphate (GTP); cardiovascular disorders; liver fibrosis |
| 05/04/2006 | US20060094768 Thiophene derivative ppar modulators |
| 05/04/2006 | US20060094751 Quinuclidine derivatives and pharmaceutical compositions containing the same |
| 05/04/2006 | US20060094746 poly(ADP-ribose) polymerase (PARP) inhibitors such as 9-hydroxythieno[2,3-c]isoquin-5(4H)-one, used for treating tumor diseases, leukaemia, sarcoma, tissue damage due to ischemia and reperfusion, inflammatory disease, retinal ischemia or brain trauma |
| 05/04/2006 | US20060094743 Isoquinoline compounds and medicinal use thereof |
| 05/04/2006 | US20060094740 Polycyclic compounds as potent alpha2-adrenoceptor antagonists |
| 05/04/2006 | US20060094735 Compounds for cell proliferation, anticancer agents, kinesin inbiitors |
| 05/04/2006 | US20060094733 Purine derivatives as liver x receptor agonists |
| 05/04/2006 | US20060094729 metastatic or non-metastatic prostate cancer; for inducing apoptosis |
| 05/04/2006 | US20060094727 Inhibitors of macrophase migration inhibitory factor and methods for identifying the same |
| 05/04/2006 | US20060094725 N-heterocyclic derivatives as NOS inhibitors |
| 05/04/2006 | US20060094724 inhibitor of activated blood coagulation factor X; N-(5-chloropyridin-2-yl)-3- {[(trans-4-pyrrolidin-1 -ylcyclohexyl)carbonyl]aznino}furo[3,2-c]pyridine-2-carboxaxnide; disorders caused by thrombi and emboli in a mammal; decreased toxicity, and causes few side effects |
| 05/04/2006 | US20060094723 Composition comprising a pde4 inhibitor and a pde5 inhibitor |
| 05/04/2006 | US20060094720 NK1 antagonists |
| 05/04/2006 | US20060094715 5-Ht4 receptor antagonists for the treatment of heart failure |
| 05/04/2006 | US20060094702 5-HT4 receptor antagonists |
| 05/04/2006 | US20060094691 Inclusion complexes of rosiglitazone |
| 05/04/2006 | US20060094667 e.g. 1,2-Dihydro-4-[(4-isopropoxyphenyl)methyl]-5-methyl-3H-pyrazol-3-one; human SGLT2 (sodium ion / glucose cotransporter 2) inhibitors; antidiabetic and hyperglycemic agents; obesity; synergistic mixture with other active compounds |
| 05/04/2006 | US20060094665 Pharmaceutical angiostatic dipeptide compositions and methods of use thereof |
| 05/04/2006 | US20060094664 Deoxycholic acid derivatives for the treatment of acute dysfunctions of portal and hepatic venous circulation |
| 05/04/2006 | US20060094657 Inhibiting development of microvessels within coronary or peripheral vessel walls for restenosis/atherosclerosis prevention or therapy |
| 05/04/2006 | US20060094650 Agent for improving life expectancy in therapy of malignant tumor |
| 05/04/2006 | US20060094043 Genes displaying enhanced expression during cellular senescence and terminal cell differentiation and uses thereof |
| 05/04/2006 | US20060094013 Salt-inducible kinases 2 and use thereof |
| 05/04/2006 | US20060093690 Novel therapeutic use of polypodium extracts |
| 05/04/2006 | US20060093612 Use of heat shock proteins to enhance efficacy of antibody therapeutics |
| 05/04/2006 | US20060093611 from mammalian chondrocyte progenitor cells expressing mechanosensitive TWIK-related potassium (TREK) ion channels; biocompatability, in vitro |
| 05/04/2006 | US20060093603 ErbB4 antagonists |
| 05/04/2006 | US20060093587 Transplants for myocardial scars |
| 05/04/2006 | US20060093574 Methods for epitope-specific and cytokine/anticytokine combination immunotherapies for modulation of pathogenic immune responses in immune mediated diseases |
| 05/04/2006 | DE102004052987A1 Composition, useful for treatment of e.g. inflammatory and obstructive respiratory complaint, sinus rhythm in heart in atrioventricular block and circulatory shock, comprises 6-hydroxy-4H-benzo1,4oxazin-3-one derivatives and other actives |
| 05/04/2006 | CA2730374A1 Compounds and compositions as inhibitors of cannabinoid receptor 1 activity |
| 05/04/2006 | CA2585642A1 Carbazole derivatives, solvates thereof, or pharmaceutically acceptable salts thereof |
| 05/04/2006 | CA2585293A1 Lip enhancement compositions |
| 05/04/2006 | CA2585177A1 Aryl sulfonic pyridoxines as antiplatelet agents |
| 05/04/2006 | CA2585174A1 Substituted pyridoxines as anti-platelet agents |
| 05/04/2006 | CA2585138A1 Process for the preparation of irbesartan hydrochloride |
| 05/04/2006 | CA2584904A1 Xanthine derivatives with hm74a receptor activity |
| 05/04/2006 | CA2583677A1 Tnf-like weak inducer of apoptosis (tweak) receptor binding domain |
| 05/04/2006 | CA2582143A1 Gene therapy for treatment of heart failure |
| 05/04/2006 | CA2581807A1 4-[(2,4-dichloro-5-methoxyphenyl)amino]-6-alkoxy-7-ethynyl-3-quinolinecarbonitriles for the treatment of ischemic injury |
| 05/03/2006 | EP1652917A1 Rna capable of inhibiting expression of klf5 gene |
| 05/03/2006 | EP1652847A1 Quinoline and quinazoline derivatives for the treatment of tumors |
| 05/03/2006 | EP1652539A1 Method of manufacturing a stent comprising an anti-angiogenic composition |
| 05/03/2006 | EP1652533A1 HEART-SLOWING DRUG CONTAINING SHORT-ACTING &bgr; BLOCKER AS THE ACTIVE INGREDIENT |
| 05/03/2006 | EP1652531A1 Use of GLP-1 or Analogues in Treatment of Stroke |
| 05/03/2006 | EP1652515A1 Process for producing drug ultramicroparticle and apparatus therefor |
| 05/03/2006 | EP1652508A1 Adhesive patch |
| 05/03/2006 | EP1651646A1 A novel process for the manufacture of (+)-(s)-clopidogrel bisulfate form-i |
| 05/03/2006 | EP1651610A1 Quinoline derivates and their use in therapy |
| 05/03/2006 | EP1651596A1 Novel derivatives of 4,4'-dithiobis-(3-aminobutane-1-sulfonates) and compositions comprising the same |
| 05/03/2006 | EP1651213A1 Use of angiotensin ii receptor antagonists, especially telmisartan, in order to increase insulin sensitivity |
| 05/03/2006 | EP1560828B1 Imidazoquinoline derivatives as adenosine a3 receptor ligands |
| 05/03/2006 | EP1528923B1 N-((3-oxo-2,3-dihydro-1h-isoindol-1-yl)acetyl)guanidine derivatives as nhe1-inhibitors for the treatment of infarction and angina pectoris |